Literature DB >> 18479118

Exploiting protein fluctuations at the active-site gorge of human cholinesterases: further optimization of the design strategy to develop extremely potent inhibitors.

Stefania Butini1, Giuseppe Campiani, Marianna Borriello, Sandra Gemma, Alessandro Panico, Marco Persico, Bruno Catalanotti, Sindu Ros, Margherita Brindisi, Marianna Agnusdei, Isabella Fiorini, Vito Nacci, Ettore Novellino, Tatyana Belinskaya, Ashima Saxena, Caterina Fattorusso.   

Abstract

Protein conformational fluctuations are critical for biological functions, although the relationship between protein motion and function has yet to be fully explored. By a thorough bioinformatics analysis of cholinesterases (ChEs), we identified specific hot spots, responsible for protein fluctuations and functions, and those active-site residues that play a role in modulating the cooperative network among the key substructures. This drew the optimization of our design strategy to discover potent and reversible inhibitors of human acetylcholinesterase and butyrylcholinesterase (hAChE and hBuChE) that selectively interact with specific protein substructures. Accordingly, two tricyclic moieties differently spaced by functionalized linkers were investigated as molecular yardsticks to probe the finest interactions with specific hot spots in the hChE gorge. A number of SAR trends were identified, and the multisite inhibitors 3a and 3d were found to be the most potent inhibitors of hBuChE and hAChE known to date.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18479118     DOI: 10.1021/jm701253t

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  8 in total

1.  Pd-catalyzed amination as an alternative to nucleophilic aromatic substitution for the synthesis of N-alkyltacrines and analogues.

Authors:  Ming Ma; Jimit Mehta; Larry D Williams; Paul R Carlier
Journal:  Tetrahedron Lett       Date:  2011-02-23       Impact factor: 2.415

2.  5-Methyl-N-(8-(5,6,7,8-tetrahydroacridin-9-ylamino)octyl)-5H-indolo[2,3-b]quinolin-11-amine: a highly potent human cholinesterase inhibitor.

Authors:  Li Wang; Ignacio Moraleda; Isabel Iriepa; Alejandro Romero; Francisco López-Muñoz; Mourad Chioua; Tsutomu Inokuchi; Manuela Bartolini; José Marco-Contelles
Journal:  Medchemcomm       Date:  2017-04-28       Impact factor: 3.597

3.  Ensemble Molecular Dynamics of a Protein-Ligand Complex: Residual Inhibitor Entropy Enhances Drug Potency in Butyrylcholinesterase.

Authors:  Eric J Sorin; Walter Alvarado; Samantha Cao; Amethyst Radcliffe; Phuc La; Yi An
Journal:  Bioenergetics       Date:  2017-01-08

4.  Multifunctional cholinesterase and amyloid Beta fibrillization modulators. Synthesis and biological investigation.

Authors:  Stefania Butini; Margherita Brindisi; Simone Brogi; Samuele Maramai; Egeria Guarino; Alessandro Panico; Ashima Saxena; Ved Chauhan; Raffaella Colombo; Laura Verga; Ersilia De Lorenzi; Manuela Bartolini; Vincenza Andrisano; Ettore Novellino; Giuseppe Campiani; Sandra Gemma
Journal:  ACS Med Chem Lett       Date:  2013-10-06       Impact factor: 4.345

5.  The discovery of potential acetylcholinesterase inhibitors: a combination of pharmacophore modeling, virtual screening, and molecular docking studies.

Authors:  Shin-Hua Lu; Josephine W Wu; Hsuan-Liang Liu; Jian-Hua Zhao; Kung-Tien Liu; Chih-Kuang Chuang; Hsin-Yi Lin; Wei-Bor Tsai; Yih Ho
Journal:  J Biomed Sci       Date:  2011-01-21       Impact factor: 8.410

6.  Development and structure-activity relationships of tanshinones as selective 11β-hydroxysteroid dehydrogenase 1 inhibitors.

Authors:  Xu Deng; Su-Ling Huang; Jian Ren; Zheng-Hong Pan; Yu Shen; Hao-Feng Zhou; Zhi-Li Zuo; Ying Leng; Qin-Shi Zhao
Journal:  Nat Prod Bioprospect       Date:  2022-09-22

Review 7.  Multitargeting nature of muscarinic orthosteric agonists and antagonists.

Authors:  Jaromir Myslivecek
Journal:  Front Physiol       Date:  2022-09-06       Impact factor: 4.755

8.  Optimization of biguanide derivatives as selective antitumor agents blocking adaptive stress responses in the tumor microenvironment.

Authors:  Kosuke Narise; Kensuke Okuda; Yukihiro Enomoto; Tasuku Hirayama; Hideko Nagasawa
Journal:  Drug Des Devel Ther       Date:  2014-06-06       Impact factor: 4.162

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.